Botulinum Toxins, Type ANeuromuscular AgentsMuscle SpasticityBotulinum ToxinsShiga Toxin 2Injections, IntramuscularBotulismShiga Toxin 1Cholera ToxinT-2 ToxinHyperhidrosisParaparesis, SpasticBotulinum AntitoxinClostridium botulinumCosmetic TechniquesShiga ToxinsAnti-Dyskinesia AgentsBlepharospasmSialorrheaTorticollisEnterotoxinsHemifacial SpasmTetanus ToxinMuscle Relaxants, CentralSkin AgingHypohidrosisBacterial ToxinsCryoanesthesiaToxemiaMarine ToxinsCytotoxinsCerebral PalsyShigella dysenteriaeHemiplegiaNeurotoxinsUpper ExtremityInjectionsEscherichia coli InfectionsLethal Dose 50Vero CellsSweat GlandsPain MeasurementTreatment OutcomeEscherichia coliEscherichia coli O157Molecular Sequence DataClostridiumAdenylate Cyclase ToxinParasympatholyticsStrokeAntitoxinsGaitRange of Motion, ArticularAmino Acid SequenceNeuromuscular JunctionHemolysin ProteinsScorpion VenomsClostridium difficileFecesQuality-Adjusted Life YearsDose-Response Relationship, DrugDouble-Blind MethodMycotoxinsSpinal Cord InjuriesBase SequenceDNA, BacterialBacterial ProteinsScorpionsEnzyme-Linked Immunosorbent AssayRicinPolymerase Chain ReactionBacillus thuringiensisPatient SatisfactionSpider VenomsADP Ribose TransferasesCost-Benefit AnalysisCnidarian VenomsFollow-Up StudiesToxoidsAdenosine Diphosphate RiboseProspective StudiesBacillus anthracisVibrio choleraeExfoliatinsClostridium perfringensKiller Factors, YeastExotoxinsEndotoxinsBordetella pertussisSea AnemonesAnthraxShellfish PoisoningQuality of LifeEnterocolitis, PseudomembranousClostridium InfectionsAntigens, BacterialVirulence FactorsGTP-Binding ProteinsTrihexosylceramidesPest Control, Biological